Assessment of type 2 diabetes prevalence in the Pakistani population of a less developed District in North Punjab

Paper Details

Research Paper 01/04/2020
Views (274) Download (29)

Assessment of type 2 diabetes prevalence in the Pakistani population of a less developed District in North Punjab

M. Waqar, G. Hira, H. Zeenat, M. Idrees
Int. J. Biosci.16( 4), 455-461, April 2020.
Certificate: IJB 2020 [Generate Certificate]


The aim of this study was to assess the current prevalence rate of type 2 diabetes in a backward rural area. This cross sectional study was conducted during April 2019 to November 2019; data was collected from diabetic patients visiting the local hospitals of district. In order to get data a stream lined questionnaire was developed, that includes type 2 diabetes diagnosis, medications, outcome, life style and success of treatment. Data was analyzed later on by SPSS version 21. The demographic data showed that 56% of diabetic patients visited the hospital were of low income class. The prevalence of diabetes was 54% in males and 61% in females. Hba1c test was also used to check the glycemic control level of patients. 12% patients had the family history of type 2 diabetes. The most commonly prescribed medicines were metformin, Glucophage and getryl respectively. In case of insulin mixtard and humulin was given. Results also showed that more than 60% of patients don’t have any awareness that when and how to self-monitor their sugar level. 5% patients had the diabetic foot infection. It was first ever study from this area showing that situation is very alarming because of higher prevalence rate, so there is a dire need to look into the complexity of the matter.


Aamir AH, Ul-Haq Z, Mahar SA. 2019. Diabetes Prevalence Survey of Pakistan(DPS-PAK): prevalence of type 2 diabetesmellitus and prediabetes using HbA1c: a population- basedsurvey from Pakistan. BMJ Open 2019. 9, e025300. https://dx.doi:10.1136/ bmjopen-2018-025300

Adeniyi OV, Yogeswaran P, Longo-Mbenza B. 2016. Cross-sectional study of patients with type 2 diabetes in OR Tambo district, South Africa BMJ Open. 2016; 6, e010875. https://dx.doi/10.1136 /bmjopen-2015-010875

Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A. 2017. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. The lancet Diabetes & endocrinology 5(8), 585-96. http://dx.doi:10.1016/S2213-8587(17)

Basit A, Fawwad A, Qureshi H, Shera AS. 2018. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 20162017. BMJopen 8(8),e020961.

Balagamwala M, Gazdar H. 2013. Agriculture and Nutrition in Pakistan: Pathways and Disconnects 1.IDS Bulletin 44(3), 66-74. 17595436.12032

Brown, Jonathan B, Christopher Conner, Gregory A, Nichols. 2010. Secondary failure of metformin mono therapy in clinical practice. Diabetes care 33(3), 501-506.

Buowari OY. 2013. Diabetes mellitus in developing countries and case series. Diabetes mellitus – Insightsand Perspectives. Rijeka, Croatia: In Tech Open. 23,131

Fowler MJ. 2008. Micro vascular and macro vascular complications of diabetes. Clinical diabetes 26(2), 77-82.

Gavin III JR, Alberti KG, Davidson MB, DeFrantz RA. 1997. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 20(7),1183. http// 10.2337/ diacare.20.7.1183

Habib SS, Aslam M. 2003. Risk factors, knowledge and health status in diabetic patients. Saudi medical Journal 24(11), 1219-24.

Hulley SB, Cummings SR, Browner WS. 2014. Designing clinical research. 3rd Ed. Lippincott Williams & Wilkins; 2007. International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes research and clinical practice 104(1), 1.

Kapur A. 2007. Economic analysis of diabetes care. Indian Journal of Medical Research 125(3), 473. http://dx.doi/10.4103/ijmr.IJMR129119

Little RR, Rohlfing CL, Sacks DB. 2011. National Glycohemoglobin Standardization Program (NGSP) Steering Committee. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for Report of a World Health Organization consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93, 299-309.

Nishtar S, Faruqui AM, Mattu MA, Mohamud KB, Ahmed A. 2004. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan-Cardiovascular diseases. JPMA. The Journal of the Pakistan Medical Association 54(12Suppl 3), 14-25.

Nishtar S. 2004. Prevention of non-communicable diseases in Pakistan: an integrated partnership-based model. Health research policy and systems 2(1), 7.

Wukich, Dane K. 2011. “Surgical site infections after foot and ankle surgery: a comparison of patients with and without diabetes.” Diabetes care 34, 2211-2213.

Yakaryılmaz, Funda Datli, Zeynel Abidin Öztürk. 2017. “Treatment of type 2 diabetes mellitus in the elderly. “World journal of diabetes 8, 6.

Yki-Järvine Hannele. 2001. Combination therapies with insulin in type 2 diabetes. Diabetes care 24(4), 758-767. 10.2337/ diacare.24.4.758

Stratton IM, Adler AI, Neil HAW. 2000. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405-412.